Thirty Madison raises $47 million for its direct to consumer treatments of hair loss, migraines, and indigestion

19:00 14.08.2020
Thirty Madison, the New York-based startup developing a range of direct to consumer treatments for hair loss, migraines, and chronic indigestion, has raised $47 million in new financing. After last week’s nearly $19 billion merger between Teladoc and Livongo, remote therapies and virtual care companies are all the rage among the healthcare industry and Thirty […]...
  897